Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application
Part of paid clinical trials in Worcester, Massachusetts.
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Study ID
- NCT06425029
- Status
- Recruiting
Conditions
- Epilepsy
- Music
- Refractory Epilepsy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Experimental Intervention (Music A) — OTHERParticipants will be asked to listen to Music A on their personal device daily, at a time most convenient for them.
- Active Comparator Intervention (Music B) — OTHERParticipants will be asked to listen to music B on their personal device daily, at a time most convenient for them.
- Active Comparator Intervention (Music C) — OTHERParticipants will be asked to listen to music C on their personal device daily, at a time most convenient for them.
Study Details
This is a prospective, placebo-controlled, double-blinded randomized study of self-administered auditory intervention in a naturalistic home environment.
Key Dates
- Start date
- Jul 22, 2025
- Status verified
- May 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Music Piece AParticipants will be asked to listen to a musical excerpt previously shown to have a positive effect on epileptic activity in human brain.
- Active Comparator: Music Piece BParticipants will be asked to listen to a musical except very similar to the experimental stimuli that has not been shown to have a positive effect on epileptic activity.
- Active Comparator: Music Piece CParticipants will select a preferred excerpt from several popular musical genres. This piece is modified to have some similarities to the experimental musical excerpt.
Primary Outcome Measure
Music Intervention and its effects on epileptic activity in human brain [ Time Frame: Baseline, Week 3-4, Week 9-10, and Weeks 13-14, (Approximately 4 1/2 Months) ]
Central Contacts
- Anastasia Kanishcheva, MPH603-650-0260
- Brian C Fidali, MD603-650-5104
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Massachusetts Chan Medical School | Worcester | Massachusetts | 01655 | CJ Hill Natalie Erlich-Malona, MD Felicia Chu, MD (SUB_INVESTIGATOR) Natalie Erlich-Malona, MD (PRINCIPAL_INVESTIGATOR) |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | Brian C Fidali, MD (PRINCIPAL_INVESTIGATOR) Barbara C Jobst, MD (SUB_INVESTIGATOR) |
Find similar trials in Worcester, MA
By condition
By specialty
Related Studies
- Human Epilepsy Genetics--Neuronal Migration Disorders StudyRecruiting · Harvard University Faculty of Medicine · Boston, Massachusetts
- Genetics of Epilepsy and Related DisordersRecruiting · Boston Children's Hospital · Boston, Massachusetts
- Methylphenidate for the Treatment of Epilepsy-related Cognitive DeficitsPHASE4 · Recruiting · VA Office of Research and Development · Miami, Florida
- Auditory Stimulation Effects on Sleep and Memory in Patients With EpilepsyEnrolling By Invitation · Massachusetts General Hospital · Boston, Massachusetts